Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

about

Clinical development of neridronate: potential for new applications.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Bisphosphonates for Paget's disease of bone in adults.

P2860

Q36754978-8A122FBF-67EF-4F96-A3F5-1AC9EBE5E1DA Q38471926-415FBC74-1FAB-4545-8B31-F0DEA0A350BB Q47387952-BBA2BAB3-995F-457D-9F8D-1D7FC62BE194

P2860

Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

Item

http://www.wikidata.org/entity/Q53064404

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Comparison of intravenous and ...... ment of Paget disease of bone.

@en

Comparison of intravenous and ...... ment of Paget disease of bone.

@nl

type

Item

label

Comparison of intravenous and ...... ment of Paget disease of bone.

@en

Comparison of intravenous and ...... ment of Paget disease of bone.

@nl

prefLabel

Comparison of intravenous and ...... ment of Paget disease of bone.

@en

Comparison of intravenous and ...... ment of Paget disease of bone.

@nl

P1476

Comparison of intravenous and ...... ment of Paget disease of bone.

@en

P2093

Annalisa Avanzati

http://www.w3.org/2001/XMLSchema#string

Beatrice Franci

http://www.w3.org/2001/XMLSchema#string

Domenico Rendina

http://www.w3.org/2001/XMLSchema#string

Gianpaolo De Filippo

http://www.w3.org/2001/XMLSchema#string

Giuseppe Martini

http://www.w3.org/2001/XMLSchema#string

Giuseppe Mossetti

http://www.w3.org/2001/XMLSchema#string

Luigi Gennari

http://www.w3.org/2001/XMLSchema#string

Maria Stella Campagna

http://www.w3.org/2001/XMLSchema#string

Pasquale Strazzullo

http://www.w3.org/2001/XMLSchema#string

Ranuccio Nuti

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.

Bisphosphonate actions: physical chemistry revisited.

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Acquired resistance to bisphosphonates in Paget's disease of bone.

Treatment of Paget's disease of bone: a survey of clinical practice in Australia.

The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.

Guidelines on the management of Paget's disease of bone.

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group.

Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion.

Update on the epidemiology of Paget's disease of bone.

P304

512-518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.237

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Merlotti

Fernando Gianfrancesco

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46125456

http://www.w3.org/2001/XMLSchema#string

P698

20814970

http://www.w3.org/2001/XMLSchema#string

Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

about

P2860

P2860

Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698